Products Category
Antibody-drug Conjugate/ADC Related
Trk Receptor
Contact Us
Tel: 0519-85788828
Fax: 0519-89960117
Mobile: 13775037613
E-mail: sales@chemrenpharm.com
Add: 169 Qingliang Road, Changzhou, Jiangsu,China
QQ:
2500035664
|
| Details: |
Description of:R788
R935788 (Fostamatinib disodium) has shown clinical activity in heavily pre-treated NHL and CLL patients, exhibits inhibitory activity against SYK but also inhibits a broad spectrum of other kinase targets. In addition to blocking FcγR-mediated events,R935788 (Fostamatinib disodium) also blocked BCR-mediated Ag presentation, thus broadly interrupting the humoral contributions to T cell-driven autoimmunity. Indeed, oral administration of R935788 (Fostamatinib disodium) significantly delayed spontaneous diabetes onset in NOD mice and successfully delayed progression of early-established diabetes even when treatment was initiated after the development of glucose intolerance. At the DC level, R788 treatment was associated with reduced insulin-specific CD8 priming and decreased DC numbers. Theoretical analysis:R788 M.Wt: 624.42 Formula: C23H24FN6O9P.2Na Solubility: Unknown Purity: >99% Storage: at -20℃ 2 years CAS No.: 1025687-58-4 Availability and price:R788 Pakage：25mg/50mg/100mg/250mg/500mg/1g/5g Stock : in stock We offer significant discount for larger quantity order. For quotation, question, and order, please send email to : sales@chemrenpharm.com Quality control data: Quality Control by H-NMR,C-NMR,LC-MS,HPLC. Product will be shipped with supporting analytical data. Fast delivery about 4-5 working days |
| Related Products : |
|
|
|
|
||||||||
|
|
|
|
Chinese
Deutsch
Espanol
Francais
Italiano
Portugues
Japanese
Korean
Arabic
Russian